3 Ways to Play the M&A Wave

Want to get in on Wall Street's wheeling and dealing without taking on the risk of gambling on the next buyout target? Try these three options instead. More 

Is M&A Mania Poised to Keep Fanning the Market’s Flames?

America's renewed push of merger & acquisition action has the potential to drive market optimism and help buoy stocks -- but which stocks, and for how long? More 

Merger Monday: Who’s the Big Winner?

Google, AstraZeneca and IHS all made headline-grabbing M&A news today, but one of them stands out above the others. More 

Stem-Cell Producer CDI Files to Go Public

Cellular Dynamics International, a top operator in the stem-cell production market, has filed to go public. More 

AstraZeneca to Purchase Omthera

AstraZeneca will purchase Omertha, a make of fish-oil based pharmaceuticals as it continues to bolster its cardiovascular product lineup More 

Should I Buy Pfizer? 3 Pros, 3 Cons

Pfizer's Q4 earnings put a small scare into investors a couple weeks back, but the pharma behemoth is built too well to ignore. More 

How Netflix (And 14 Other Blue Chips) Got Its Groove Back

Here is a list of 15 companies that have turned their businesses around, led by Netflix, which is now humming along with profitability and a soaring stock price More